Commercial Services Relating to Recombinant Antibody Discovery and Antigen Generation

Dstl has a requirement to access commercially available services related to antibody display library generation and antigen generation.

The Authority (Dstl) operates a mature programme of hybridoma-based antibody discovery and characterisation and is rapidly maturing a recombinant antibody-based approach to replace or augment the current approach. There are a number of drivers in place that promote delivering many of the aspects of this programme within Industry whilst retaining safety and security limited steps, as well as activities that maintain intelligent customer status, within Dstl.